Vanguard Group Inc Abb Vie Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 171,647,841 shares of ABBV stock, worth $28.8 Billion. This represents 0.62% of its overall portfolio holdings.

Number of Shares
171,647,841
Previous 170,659,546 0.58%
Holding current value
$28.8 Billion
Previous $29.3 Billion 15.8%
% of portfolio
0.62%
Previous 0.57%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$163.84 - $199.33 $162 Million - $197 Million
988,295 Added 0.58%
171,647,841 $33.9 Billion
Q2 2024

Aug 13, 2024
BUY
$154.79 - $180.76 $43.8 Million - $51.1 Million
282,800 Added 0.17%
170,659,546 $29.3 Billion
Q1 2024

May 10, 2024
BUY
$159.82 - $182.1 $1.59 Billion - $1.82 Billion
9,978,415 Added 6.22%
170,376,746 $31 Billion
Q4 2023

Mar 11, 2024
BUY
$137.6 - $154.97 $6,880 - $7,748
50 Added 0.0%
160,398,331 $24.9 Billion
Q4 2023

Feb 14, 2024
SELL
$137.6 - $154.97 $48 Million - $54.1 Million
-349,074 Reduced 0.22%
160,398,281 $24.9 Billion
Q3 2023

Nov 14, 2023
BUY
$133.59 - $154.65 $194 Million - $224 Million
1,450,089 Added 0.91%
160,747,355 $24 Billion
Q2 2023

Aug 14, 2023
SELL
$132.51 - $164.9 $155 Million - $193 Million
-1,169,081 Reduced 0.73%
159,297,266 $21.5 Billion
Q1 2023

Jul 14, 2023
BUY
$144.61 - $166.54 $2.78 Million - $3.21 Million
19,254 Added 0.01%
160,466,347 $25.6 Billion
Q1 2023

May 15, 2023
BUY
$144.61 - $166.54 $308 Million - $355 Million
2,129,541 Added 1.35%
160,447,093 $25.6 Billion
Q4 2022

Feb 10, 2023
BUY
$138.31 - $165.87 $317 Million - $381 Million
2,295,138 Added 1.47%
158,317,552 $25.6 Billion
Q3 2022

Nov 14, 2022
BUY
$134.21 - $153.93 $328 Million - $376 Million
2,442,663 Added 1.59%
156,022,414 $20.9 Billion
Q2 2022

Aug 12, 2022
BUY
$137.62 - $174.96 $421 Million - $536 Million
3,060,971 Added 2.03%
153,579,751 $23.5 Billion
Q1 2022

May 13, 2022
BUY
$131.98 - $163.75 $555 Million - $689 Million
4,206,711 Added 2.88%
150,518,780 $24.4 Billion
Q4 2021

Feb 14, 2022
BUY
$107.43 - $135.93 $84.1 Million - $106 Million
782,554 Added 0.54%
146,312,069 $19.8 Billion
Q3 2021

Nov 12, 2021
BUY
$106.4 - $120.78 $88.9 Million - $101 Million
835,949 Added 0.58%
145,529,515 $15.7 Billion
Q2 2021

Aug 13, 2021
BUY
$105.21 - $117.21 $15.2 Billion - $17 Billion
144,693,566 New
144,693,566 $16.3 Billion

Others Institutions Holding ABBV

# of Institutions
3,846
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email